Index of reports
> Serious Reactions (402)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 402 Next >>
Possible Reyataz side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: 36 year old female
Reactions: Maternal Exposure During Pregnancy, Abortion Induced
Drug(s) suspected as cause:
Epivir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiviral Treatment
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Viread
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Possible Reyataz side effects in 31 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: 31 year old female
Reactions: Abortion Spontaneous
Drug(s) suspected as cause:
Norvir
Dosage: 100 mg/day taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Reyataz
Dosage: 300 mg/day taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Truvada
Dosage: 1 tab/caps daily taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Possible Reyataz side effects in 66 year old male
Reported by a physician from Japan on 2012-08-24
Patient: 66 year old male
Reactions: Glomerulonephritis Chronic
Drug(s) suspected as cause:
Epzicom
Dosage: 1df: 1tab
Administration route: Oral
Indication: HIV Infection
Start date: 2007-06-27
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-15
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-15
Other drugs received by patient: Depakene
Possible Reyataz side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 36 year old female
Reactions: Abortion Induced
Drug(s) suspected as cause:
Epivir
Administration route: Oral
Indication: Antiretroviral Therapy
Norvir
Dosage: daily
Administration route: Oral
Indication: Antiretroviral Therapy
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Viread
Administration route: Oral
Indication: Antiretroviral Therapy
Possible Reyataz side effects in 26 year old female
Reported by a physician from United States on 2012-08-23
Patient: 26 year old female
Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced
Drug(s) suspected as cause:
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Raltegravir
Dosage: 800mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Reyataz side effects in
Reported by a physician from United States on 2012-08-23
Patient: , weighing 1.9 kg (4.2 pounds)
Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation
Drug(s) suspected as cause:
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Raltegravir
Dosage: 800mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: female
Reactions: Amniotic Fluid Volume Decreased, Abortion Spontaneous
Drug(s) suspected as cause:
Norvir
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Reyataz
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Truvada
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male, weighing 3.7 kg (8.2 pounds)
Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-17
Patient: female
Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-16
Patient: female
Reactions: Oligohydramnios, Abortion Induced, Pregnancy
Drug(s) suspected as cause:
Norvir
Dosage: 1 film coated tablet daily
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-24
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-24
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2011-01-24
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: female
Reactions: Abortion Spontaneous
Drug(s) suspected as cause:
Emtricitabine / Tenofovir Disoproxil Fumarate
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-17
Reyataz
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-17
Ritonavir
Dosage: 100 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-08-17
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient: female
Reactions: Abortion Spontaneous
Drug(s) suspected as cause:
Norvir
Dosage: 100 mg/day taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Reyataz
Dosage: 300 mg/day taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Truvada
Dosage: 1 tab/caps daily taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-08-17
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14
Patient: female
Reactions: Weight Increased
Drug(s) suspected as cause:
Norvir
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2011-08-22
End date: 2012-03-13
Reyataz
Dosage: 2 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2011-08-22
End date: 2012-03-13
Truvada
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-04-14
Possible Reyataz side effects in 39 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient: 39 year old female
Reactions: Foetal Death, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Norvir
Dosage: not taken at conception
Administration route: Oral
Start date: 2011-07-01
Norvir
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-07-01
End date: 2011-05-20
Reyataz
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-07-01
End date: 2011-05-20
Reyataz
Dosage: not taken at conception
Administration route: Oral
Start date: 2011-07-01
Truvada
Dosage: 1 tab/caps not taken at conception
Administration route: Oral
Start date: 2011-07-01
Truvada
Dosage: 1 tab/caps taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-07-01
End date: 2011-05-20
Other drugs received by patient: Aldomet; Labetalol HCL
Possible Reyataz side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-14
Patient: male
Reactions: T-Lymphocyte Count Decreased
Drug(s) suspected as cause:
Reyataz
Zerit
Other drugs received by patient: Lovaza; Fish OIL; Vitamin D; Vitamin A Palmitate
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-14
Patient: female
Reactions: Weight Increased, Liver Disorder
Drug(s) suspected as cause:
Norvir
Indication: HIV Infection
Start date: 2008-04-01
End date: 2009-06-01
Norvir
Administration route: Oral
Start date: 2011-08-22
End date: 2012-04-13
Reyataz
Administration route: Oral
Start date: 2011-08-22
End date: 2012-03-13
Reyataz
Indication: HIV Infection
Start date: 2008-08-01
End date: 2009-06-01
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2008-04-14
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient: female
Reactions: Amniotic Fluid Volume Decreased, Abortion Spontaneous
Drug(s) suspected as cause:
Norvir
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Reyataz
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Truvada
Dosage: taken at conception
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-01-24
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in 57 year old female
Reported by a physician from United States on 2012-08-10
Patient: 57 year old female
Reactions: Chronic Obstructive Pulmonary Disease, Myocardial Infarction, Arrhythmia
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient: 30 year old female
Reactions: Abortion Induced
Drug(s) suspected as cause:
Norvir
Administration route: Oral
Indication: Antiviral Treatment
Reyataz
Administration route: Oral
Indication: Antiviral Treatment
Truvada
Administration route: Oral
Indication: Antiviral Treatment
Possible Reyataz side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-08
Patient: female
Reactions: Genital Labial Adhesions
Drug(s) suspected as cause:
Norvir
Prezista
Reyataz
Truvada
Possible Reyataz side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-08
Patient: 30 year old female
Reactions: Stillbirth, Maternal Exposure During Pregnancy
Drug(s) suspected as cause:
Epzicom
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2010-05-01
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiviral Treatment
Start date: 2011-05-01
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiviral Treatment
Start date: 2010-05-01
Possible Reyataz side effects in 40 year old female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-08-08
Patient: 40 year old female
Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Epivir
Dosage: 600mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-03-22
Intelence
Dosage: 400mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-04-19
End date: 2011-06-14
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-06-16
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-04-04
End date: 2011-04-18
Retrovir
Dosage: 800mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-06-16
Reyataz
Dosage: 800mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-04-19
End date: 2011-06-16
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Start date: 2011-04-04
End date: 2011-04-18
Possible Reyataz side effects in 44 year old female
Reported by a pharmacist from United Kingdom on 2012-08-08
Patient: 44 year old female
Reactions: Dysphagia, Cerebrovascular Accident
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 66 year old female
Reported by a physician from Germany on 2012-08-07
Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Rhabdomyolysis, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Reyataz
Other drugs received by patient possibly interacting with the suspect drug: Simvastatin
Dosage: for about 10 days
Administration route: Oral
Indication: Coronary Artery Disease
Possible Reyataz side effects in 26 year old female
Reported by a physician from United States on 2012-08-07
Patient: 26 year old female
Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced
Drug(s) suspected as cause:
Combivir
Dosage: 2tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Raltegravir
Dosage: 800mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Reyataz
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient: , weighing 1.9 kg (4.2 pounds)
Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation
Drug(s) suspected as cause:
Combivir
Dosage: 2tab per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Norvir
Dosage: 100mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Raltegravir
Dosage: 800mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-11-21
Reyataz
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Truvada
Dosage: 1tab per day
Indication: Antiretroviral Therapy
Start date: 2011-07-13
End date: 2011-10-27
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-06
Patient: female
Reactions: Oligohydramnios, Abortion Induced, Pregnancy
Drug(s) suspected as cause:
Norvir
Dosage: 1 film coated tablet daily
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-24
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2012-01-24
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2011-01-24
Possible Reyataz side effects in female
Reported by a pharmacist from Canada on 2012-08-03
Patient: female
Reactions: Microcephaly, Foetal Exposure During Pregnancy, Infantile Spasms
Drug(s) suspected as cause:
Norvir
Indication: Product Used FOR Unknown Indication
Reyataz
Indication: Product Used FOR Unknown Indication
Truvada
Indication: Product Used FOR Unknown Indication
Page 1 Next >>
|